[go: up one dir, main page]

WO2009057775A1 - アミノ酸組成物を含有する疲労防止剤 - Google Patents

アミノ酸組成物を含有する疲労防止剤 Download PDF

Info

Publication number
WO2009057775A1
WO2009057775A1 PCT/JP2008/069938 JP2008069938W WO2009057775A1 WO 2009057775 A1 WO2009057775 A1 WO 2009057775A1 JP 2008069938 W JP2008069938 W JP 2008069938W WO 2009057775 A1 WO2009057775 A1 WO 2009057775A1
Authority
WO
WIPO (PCT)
Prior art keywords
weight
parts
amino acid
acid composition
fatigue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2008/069938
Other languages
English (en)
French (fr)
Inventor
Masato Saito
Hiroyuki Arita
Masanori Takamura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Meiji Dairies Corp
Original Assignee
Meiji Dairies Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Dairies Corp filed Critical Meiji Dairies Corp
Priority to EP08843904.7A priority Critical patent/EP2210601B1/en
Priority to AU2008319747A priority patent/AU2008319747B2/en
Priority to NZ585153A priority patent/NZ585153A/en
Priority to CN200880114298A priority patent/CN101842094A/zh
Priority to JP2009539139A priority patent/JP5775668B2/ja
Priority to CA2703693A priority patent/CA2703693C/en
Priority to US12/740,934 priority patent/US20100267794A1/en
Publication of WO2009057775A1 publication Critical patent/WO2009057775A1/ja
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401—Proline; Derivatives thereof, e.g. captopril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4172—Imidazole-alkanecarboxylic acids, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Toxicology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

従来のアミノ酸組成物では、運動能力向上や脂肪燃焼促進が主目的であった。本発明では、筋肉疲労と神経疲労との双方を同時に防止することができる疲労防止剤を提供する。特定種および特定量のアミノ酸からなるアミノ酸組成物を含む疲労防止剤により、筋肉疲労と神経疲労との双方を同時に防止することができる。このとき、アミノ酸組成物の種類と量比としては、プロリンを３０～２００重量部、グリシンを６０～１４０重量部、アラニンを５０～２６０重量部、リジンを５０～１３０重量部、トリプトファンを３０～７５重量部、ヒスチジンを２０～４０重量部で含むことが好ましく、さらに、チロシンを３～７５重量部、アルギニンを１５～４５重量部で含むことがより好ましく、さらに、バリンを３０～５５重量部、ロイシンを３５～６０重量部、イソロイシンを２５～６０重量部で含むことがさらに好ましい。
PCT/JP2008/069938 2007-10-31 2008-10-31 アミノ酸組成物を含有する疲労防止剤 Ceased WO2009057775A1 (ja)

Priority Applications (7)

Application Number Priority Date Filing Date Title
EP08843904.7A EP2210601B1 (en) 2007-10-31 2008-10-31 Anti-fatigue agent comprising amino acid composition
AU2008319747A AU2008319747B2 (en) 2007-10-31 2008-10-31 Anti-fatigue agent comprising amino acid composition
NZ585153A NZ585153A (en) 2007-10-31 2008-10-31 Anti-fatigue agent comprising amino acid composition
CN200880114298A CN101842094A (zh) 2007-10-31 2008-10-31 含有氨基酸组合物的抗疲劳剂
JP2009539139A JP5775668B2 (ja) 2007-10-31 2008-10-31 アミノ酸組成物を含有する疲労防止剤
CA2703693A CA2703693C (en) 2007-10-31 2008-10-31 Anti-fatigue agent comprising amino acid composition
US12/740,934 US20100267794A1 (en) 2007-10-31 2008-10-31 Anti-fatigue agent comprising amino acid composition

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007282970 2007-10-31
JP2007-282970 2007-10-31

Publications (1)

Publication Number Publication Date
WO2009057775A1 true WO2009057775A1 (ja) 2009-05-07

Family

ID=40591155

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/069938 Ceased WO2009057775A1 (ja) 2007-10-31 2008-10-31 アミノ酸組成物を含有する疲労防止剤

Country Status (10)

Country Link
US (1) US20100267794A1 (ja)
EP (1) EP2210601B1 (ja)
JP (2) JP5775668B2 (ja)
KR (1) KR20100094485A (ja)
CN (2) CN101842094A (ja)
AU (1) AU2008319747B2 (ja)
CA (1) CA2703693C (ja)
HK (1) HK1210594A1 (ja)
NZ (1) NZ585153A (ja)
WO (1) WO2009057775A1 (ja)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110166085A1 (en) * 2008-04-29 2011-07-07 Beck-Hoven Van Rudolf Composition comprising carbohydrates and peptides which comprise tryptophan
JP2011148769A (ja) * 2009-12-25 2011-08-04 Lion Corp 分枝鎖アミノ酸分解抑制剤
WO2012169600A1 (ja) * 2011-06-07 2012-12-13 味の素株式会社 アミノ酸組成物
JP2016014007A (ja) * 2014-06-13 2016-01-28 花王株式会社 筋タンパク質合成シグナル活性化剤

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102613653A (zh) * 2012-04-17 2012-08-01 安吉东来药用辅料有限责任公司 一种含γ-氨基丁酸的营养素饮料及其制备方法
CN103005435B (zh) * 2012-12-13 2014-01-29 北京康比特体育科技股份有限公司 一种抗疲劳、提高速度耐力的组合物及含其制剂
EP3078375B1 (en) * 2013-10-09 2021-05-12 Ajinomoto Co., Inc. Anti-fatigue composition
CN105011945B (zh) * 2015-06-23 2017-11-07 山东理工大学 一种预防驾驶疲劳的控制方法及系统
KR101997336B1 (ko) * 2017-07-18 2019-07-08 연세대학교 산학협력단 에틸바닐린을 유효성분으로 함유하는 근력강화, 근육증강, 근육분화, 근육재생 또는 근감소증 억제효과를 갖는 조성물
WO2020045612A1 (ja) 2018-08-31 2020-03-05 味の素株式会社 間欠的持久力向上剤または血中ｐＨ上昇剤
CN111528484A (zh) * 2020-05-08 2020-08-14 大连医诺生物股份有限公司 一种促运动后疲劳恢复的组合物、其制备方法及应用
JP2021050244A (ja) * 2021-01-07 2021-04-01 株式会社東洋新薬 抗疲労剤
CN117881300A (zh) * 2021-08-18 2024-04-12 株式会社日皮 抑制肌肉疲劳和/或急性肌肉痛的食品组合物
KR102517807B1 (ko) * 2022-07-14 2023-04-05 코리아콜라겐(주) 신체 에너지 활성 드링크 분말 조성물 및 이를 포함하는 신체 에너지 활성 드링크 분말
KR102774426B1 (ko) * 2024-05-24 2025-02-27 (주)아드리움 L-로이신을 포함하는 기능성 건강기능식품

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03129318A (ja) * 1989-10-16 1991-06-03 Ricoh Co Ltd レーザビーム径制御装置
US5026721A (en) * 1989-06-05 1991-06-25 Dudrick Stanley J Amino acid nutritional supplement and regimen for enhancing physical performance through sound nutrition
JP2518692B2 (ja) 1989-06-14 1996-07-24 理化学研究所 筋力持続剤，滋養強壮剤，輸液用剤，栄養補給剤，疲労回復剤及び乳酸生成調節剤
JPH08198748A (ja) 1995-01-27 1996-08-06 Ajinomoto Co Inc アミノ酸栄養組成物
WO2002034257A1 (fr) 2000-10-27 2002-05-02 Meiji Dairies Corporation Agents de recuperation ou de prevention de la fatigue dans le systeme nerveux central et aliments de recuperation ou de prevention associes
WO2004028528A1 (ja) * 2002-09-30 2004-04-08 Riken 中枢機能改善用アミノ酸組成物
JP2004352696A (ja) * 2003-05-30 2004-12-16 Institute Of Physical & Chemical Research アミノ酸組成物及び補液
JP3814683B2 (ja) * 1996-01-09 2006-08-30 独立行政法人理化学研究所 アミノ酸組成物
WO2007145239A1 (ja) * 2006-06-13 2007-12-21 Meiji Dairies Corporation アミノ酸組成物を含有する疲労防止剤
WO2008105368A1 (ja) * 2007-02-28 2008-09-04 Meiji Dairies Corporation アミノ酸組成物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3553992B2 (ja) * 1993-05-28 2004-08-11 独立行政法人理化学研究所 代謝調節剤
KR19990077107A (ko) * 1996-01-09 1999-10-25 코바야시 순이치 아미노산 조성물
JP2000072669A (ja) * 1998-08-24 2000-03-07 Inst Of Physical & Chemical Res アミノ酸・糖組成物

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5026721A (en) * 1989-06-05 1991-06-25 Dudrick Stanley J Amino acid nutritional supplement and regimen for enhancing physical performance through sound nutrition
JP2518692B2 (ja) 1989-06-14 1996-07-24 理化学研究所 筋力持続剤，滋養強壮剤，輸液用剤，栄養補給剤，疲労回復剤及び乳酸生成調節剤
JPH03129318A (ja) * 1989-10-16 1991-06-03 Ricoh Co Ltd レーザビーム径制御装置
JPH08198748A (ja) 1995-01-27 1996-08-06 Ajinomoto Co Inc アミノ酸栄養組成物
JP3814683B2 (ja) * 1996-01-09 2006-08-30 独立行政法人理化学研究所 アミノ酸組成物
WO2002034257A1 (fr) 2000-10-27 2002-05-02 Meiji Dairies Corporation Agents de recuperation ou de prevention de la fatigue dans le systeme nerveux central et aliments de recuperation ou de prevention associes
WO2004028528A1 (ja) * 2002-09-30 2004-04-08 Riken 中枢機能改善用アミノ酸組成物
JP2004352696A (ja) * 2003-05-30 2004-12-16 Institute Of Physical & Chemical Research アミノ酸組成物及び補液
WO2007145239A1 (ja) * 2006-06-13 2007-12-21 Meiji Dairies Corporation アミノ酸組成物を含有する疲労防止剤
WO2008105368A1 (ja) * 2007-02-28 2008-09-04 Meiji Dairies Corporation アミノ酸組成物

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
"Analysis of sex difference in immuno-response system during exercise fatigue", BIOCHEMISTRY, vol. 77, 2005, pages 1056
A. H. FORSLUND ET AL., AM. J. PHYSIOL ENDOCRINOL METAB., vol. 278, 2000, pages 857 - 867
G. AHLBORG ET AL., THE JOURNAL OF CLINICAL INVESTIGATION, vol. 53, April 1974 (1974-04-01), pages 1080 - 1090
KANDO KOBAYASHI: "Sport to Amino-san Supplement", SHOKU NO KAGAKU, vol. 255, 1999, pages 93 - 88, XP008141118 *
See also references of EP2210601A4
T. L. BAZZARE ET AL., JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION, vol. 11, no. 5, 1992, pages 501 - 511

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110166085A1 (en) * 2008-04-29 2011-07-07 Beck-Hoven Van Rudolf Composition comprising carbohydrates and peptides which comprise tryptophan
US10172375B2 (en) * 2008-04-29 2019-01-08 Dsm Ip Assets B.V. Compositions comprising carbohydrates and peptides which comprise tryptophan
JP2011148769A (ja) * 2009-12-25 2011-08-04 Lion Corp 分枝鎖アミノ酸分解抑制剤
WO2012169600A1 (ja) * 2011-06-07 2012-12-13 味の素株式会社 アミノ酸組成物
JPWO2012169600A1 (ja) * 2011-06-07 2015-02-23 味の素株式会社 アミノ酸組成物
JP2017155052A (ja) * 2011-06-07 2017-09-07 味の素株式会社 アミノ酸組成物
JP2016014007A (ja) * 2014-06-13 2016-01-28 花王株式会社 筋タンパク質合成シグナル活性化剤

Also Published As

Publication number Publication date
KR20100094485A (ko) 2010-08-26
HK1210594A1 (en) 2016-04-29
CN101842094A (zh) 2010-09-22
JP5798648B2 (ja) 2015-10-21
US20100267794A1 (en) 2010-10-21
JP5775668B2 (ja) 2015-09-09
EP2210601A1 (en) 2010-07-28
AU2008319747A1 (en) 2009-05-07
JP2014129394A (ja) 2014-07-10
CA2703693A1 (en) 2009-05-07
NZ585153A (en) 2012-01-12
EP2210601B1 (en) 2017-07-19
CA2703693C (en) 2016-06-28
JPWO2009057775A1 (ja) 2011-03-10
AU2008319747B2 (en) 2013-04-18
CN104922115A (zh) 2015-09-23
EP2210601A4 (en) 2011-02-09

Similar Documents

Publication Publication Date Title
WO2009057775A1 (ja) アミノ酸組成物を含有する疲労防止剤
TW200509899A (en) Amino acid composition and supplemental solution
CA2280612A1 (en) Amino acid-sugar composition
WO2008089491A3 (en) Modifications of peptide compositions to increase stability and delivery efficiency
WO2007133642A8 (en) Sport drink containing amino acids and carbohydrates
WO2008105368A1 (ja) アミノ酸組成物
WO2005023866A3 (en) Peptides that inhibit complement activation
WO2008094176A3 (en) Ilt3 binding molecules and uses therefor
ZA200803349B (en) Compositions and methods for increasing lean muscle mass and/or reducing fat gain
WO2008151005A3 (en) Compositions and methods for tissue repair
EA201001223A1 (ru) Стабилизированные белковые композиции
RU2011148127A (ru) Бековая смесь на основе гороха и ее применение в жидкой питательной композиции, пригодной для энтерального питания
WO2010026010A3 (de) Haarbehandlungsmittel mit niedrigdosierten oligopeptiden
US20060247313A1 (en) Amino acid composition promoting collagen synthesis
WO2009004315A8 (en) Isolated peptides and uses thereof
MY192981A (en) Cyclosporine analogue molecules modified at amino acid 1 and 3
WO2005034932A3 (en) Amino acid based compositions for the treatment of pathological conditions distinguished by insufficient mitochondrial function
CA2504377A1 (en) Pharmaceutical preparation of recombinant factor viii lyophilized without albumin as a stabilizer
ATE523095T1 (de) Aminosäurenkonzentrat in wässrigem gel und mittels verdünnung besagten konzentrats mit wasser erhaltenes getränk zur bekämpfung von müdigkeit
CA2455776A1 (en) Amino-acid-based compositions, suitable in therapy for the healing and/or mending of wounds and lesions, in particular for application in the ophthalmic field
CA2449917A1 (en) Amino acid mixture-containing agent capable of raising body temperature for food or drink use and medical use
WO2002102360A3 (en) Compositions based on branched chain amino acids for improving the myocardial ventricular function in patients suffering from diabetes
WO2009108713A3 (en) Topical compositions and methods utilizing peptides containing lipid-modified cysteine-containing peptides
WO2009073909A8 (de) Zyklisches, cystein-freies protein
WO2008149668A1 (ja) タンパク質含有組成物

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200880114298.1

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08843904

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 2703693

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2009539139

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 12740934

Country of ref document: US

NENP Non-entry into the national phase

Ref country code: DE

REEP Request for entry into the european phase

Ref document number: 2008843904

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 585153

Country of ref document: NZ

Ref document number: 2008319747

Country of ref document: AU

Ref document number: 2008843904

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 20107011815

Country of ref document: KR

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: 2008319747

Country of ref document: AU

Date of ref document: 20081031

Kind code of ref document: A